Nvidia stock price may 30 2025 the projected EPS growth rate

The projected EPS growth rate reinforces bullish expectations for "nvidia stock price May 30 2025", with consensus models showing double-digit revenue growth year-over-year. For a while, it looked like Pfizer's stock was destined for another year in the red. The U.S. government has been targeting pharma companies with tariffs this year, and tougher vaccine policies have also been weighing on the company's valuation. Additionally, Vanguard economist Josh Hirt said in a note to keep an eye on potential "upward revisions to January and March PCEs due to [producer price index] revisions of hospitals, physicians, and insurance services." Price action patterns indicate a strong uptrend for "nvidia stock price May 30 2025", correlating with higher R&D spending and new product announcements in Q2 FY